(Q44389362)

English

Combined bedtime insulin--daytime sulphonylurea regimen compared with two different daily insulin regimens in type 2 diabetes: effects on HbA1c and hypoglycaemia rate--a randomised trial

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Combined bedtime insulin--daytime sulphonylurea regimen compared with two different daily insulin regimens in type 2 diabetes: effects on HbA1c and hypoglycaemia rate--a randomised trial (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

F J Snoek

0 references

Robert J. Heine

8

object named as

R J Heine

1 reference

Europe PubMed Central

2 December 2017

author name string

M H A Stehouwer

1

1 reference

Europe PubMed Central

2 December 2017

J H DeVries

2

1 reference

Europe PubMed Central

2 December 2017

J A E Lumeij

3

1 reference

Europe PubMed Central

2 December 2017

H J Adèr

4

1 reference

Europe PubMed Central

2 December 2017

A M S Engbers

5

1 reference

Europe PubMed Central

2 December 2017

A van Iperen Av

6

1 reference

Europe PubMed Central

2 December 2017

F J Snoek

7

1 reference

Europe PubMed Central

2 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

2 December 2017

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

2 December 2017

19

1 reference

Europe PubMed Central

2 December 2017

2

1 reference

Europe PubMed Central

2 December 2017

148-152

1 reference

Europe PubMed Central

2 December 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

21 January 2018

Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

21 January 2018

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of different insulin regimens in elderly patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Low Prevalence of Antibodies to GAD65 in a 50- to 74-Year-Old General Dutch Population: The Hoorn Study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapies with insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.356

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.356

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44389362&oldid=2020795596"